Adding defensive healthcare stocks can be a great way to ride out continued volatility in the market. AbbVie (ABBV): Investors are overreacting to this venerable big pharma company’s recent earnings report. Amgen (AMGN): An established biotech company with a high forward dividend yield (3.33%). Baxter International (BAX): A reasonably-priced medical products provider on track to
0 Comments
Alphabet’s (NASDAQ:GOOGL, NASDAQ:GOOG) first-quarter results came in substantially below estimates. However, Wall Street analysts remain bullish on GOOG stock’s long-term prospects. During the first quarter, the company’s revenue fell far below analyst expectations as it confronted inflation, supply chain issues and fallout from Russia’s invasion of Ukraine. The company said it made a quarterly profit
0 Comments
With stability becoming a major concern under present volatile conditions, these high-yielding dividend stocks to buy offer much-needed comfort. Rio Tinto (RIO): Featuring a yield of nearly 12% and a relevant business, RIO deserves a long look among dividend stocks to buy. China Petroleum & Chemical (SNP): While suffering from the pandemic and severe geopolitical
0 Comments
Investors seeking exposure to the driverless car revolution now have the option of buying into exchange-traded funds (ETFs) specifically dedicated to driverless cars, electric vehicles, and other innovations in the automobile industry. Among this class of ETFs are KraneShares Electric Vehicles and Future Mobility ETF (KARS), which debuted in January of 2018; InnovationShares NextGen Vehicle and
0 Comments
Pfizer (PFE) stock looks cheap after reporting record results from its Covid-19 vaccine. The rest of the year should look even better as sales ramp up for its Covid-19. Investors should worry about where its new CFO invests the cash. Source: Manuel Esteban / Shutterstock.com Pfizer (NYSE:PFE) stock rose 2% after earnings beat street estimates.
0 Comments